Results 91 to 100 of about 16,073 (189)
レニン-アンジオテンシン系抑制薬は透析療法を受けている糖尿病性腎症患者の左室肥大を抑制する [PDF]
, 2003 Background: LVH is frequently found in diabetic and hypertensive patients at the initiation of dialysis therapy and is highly predictive of future cardiac morbidity and mortality.
金子 敬子
core
Zhongguo shiyan zhenduanxue, 2015 目的探讨高通量血液透析联合左卡尼汀改善尿毒症患者贫血的临床作用。方法将血液透析的尿毒症患者88例,按使用透析器种类的不同和透析后是否应用左卡尼汀分为A（低通量透析器组）、B（低通量透析器+左卡尼汀组）、C（高通量透析器组）、D（高通量透析器+左卡尼汀组）4组,每组22例。A组给予F7透析机透析（3次/周,4小时/次）;B组给予F7透析机透析（3次/周,4小时/次）,配合左卡尼汀静脉注射（5mg/次）。C组给予FX60透析机透析（3次/周,4小时/次）;D组给予（口服,2.5mg,1次/日 ...
梁波 +4 more
doaj
Statistics on operations at Hara Genitourinary Hospital (1971-1991) [PDF]
, 1992 The statistical analysis of the inpatients and operations in our department from April, 1971 to March, 1991 revealed a total of 9, 170 operations. One of the biggest changes in treatment is a marked increase in closed surgery.
下垣, 博義 +15 more
core
Linchuang shenzangbing zazhi, 2018 对具有出血倾向患者进行血液透析时使用肝素或低分子肝素等抗凝剂可引起或加重出血甚至危及患者生命[1]。采用无抗凝透析可以有效地避免出血的发生,所以无抗凝透析在临床上被广泛应用于伴有高危出血倾向的血液透析患者,而无抗凝透析最主要的并发症是凝血,这既影响透析效果,又易造成患者失血[2]。采用无抗凝透析常规生理盐水100200ml,每3060min间断冲洗体外循环通路是目前国内普遍做法已得到充分肯定[3 ...
相欣洁, 秦耀荣, 吴楠楠
doaj
Linchuang shenzangbing zazhi, 2015 血液透析能够有效过滤体内有害物质,是终末期肾病主要的肾脏替代疗法。近年来中心静脉置管(central venous catheter,CVC)的血液透析患者比例呈现增加趋势,中心静脉狭窄(central venous stenosis,CVS)是与血液透析相关的最为棘手和严重的并发症,可引起严重的临床症状并影响血管通路的使用及其寿命,临床对其治疗的目的在于缓解症状,维持血管通路的长期通畅,保证血液透析的正常进行。一、CVS的危险因素CVC是导致CVS发生的重要危险因素 ...
严泽振, 张岚
doaj
A case of transitional cell carcinoma occurring in the bladder and bilateral renal pelvis [PDF]
, 1984 A 41-year-old male patient underwent transurethral resection for multiple bladder tumors in January, 1979. The pathological examination of the specimen revealed non-invasive transitional cell carcinoma G 2.
佐久間, 芳文 +4 more
core